those patients who survive usually undergo repair of the defect with the original bone or with a prosthetic implant. The risks of decompressive craniectomy are therefore not only limited to the initial operation, but also include complications that may occur during subsequent cranioplasty with bone flap replacement. 4, 12, 14, 36 Risks of cranioplasty include injury to the underlying cortex, infection, CSF fistula, epidural or subdural hematoma, and IPH. 3, 20, 24, 25, 38 Many of these complications result from difficulties with soft-tissue plane dissection required to expose and prepare the cranial defect for repair, and are significantly worse in patients with scarring between the brain surface and overlying galea aponeurotica and temporalis muscle. 3, 20, 24, 25, 38 A limited number of studies have described decompressive craniectomy techniques that may reduce the morbidity associated with subsequent cranioplasty. 3, 17, 20, 24, 25, 38 Some groups have focused on the lack of a dural layer over the decompressed cortical surface, and have described recreating this barrier by performing a watertight expansile duraplasty or using an onlay dural substitute technique. 24, 25, 38 Others groups attempt to correct for the lack of a structural barrier between the intracranial contents and the temporalis muscle and scalp by using a synthetic barrier at the time of decompressive craniectomy. 3, 20 A modified technique that accounts for both the lack of a dural layer and the lack of bone to physically separate the galea and temporalis muscle from intracranial structures has not been previously described. We present our institutional experience with decompressive craniectomy using a multilayered onlay repair with both a collagen-based dural substitute (DuraGen; Integra LifeSciences), as well as a gelatin film barrier that prevents scarring and tissue adhesion (Gelfilm; Pfizer).
Methods

Study Population
After Institutional Board Review approval, we conducted a retrospective chart review on 62 consecutive patients who underwent decompressive craniectomy surgery for a variety of clinical indications, including TBI with significant mass effect and midline shift, malignant MCA infarction, and elevated ICP refractory to maximal medical management. The decision to perform a unilateral hemicraniectomy or bifrontal craniectomy was made by the treating physician based on the pattern of intracranial hemorrhage, compression of basal cisterns, and the presence of midline shift, applying an institutional protocol based on currently available guidelines 2 and clinical trial data. 13, 19, 37 Decompressive Craniectomy Technique A frontotemporoparietal hemicraniectomy was performed using a standard, large, question mark-shaped musculocutaneous flap based on the root of the zygoma; a bifrontal craniectomy was performed using a linear bicoronal musculocutaneous flap. 31, 32 The lateral sphenoid wing and the squamous portion of the temporal bone were resected to maximize temporal lobe and middle fossa decompression. The goal of decompressive craniectomy was to achieve a final craniectomy size of at least 12 cm (craniocaudal) × 15 cm (anteroposterior). If the frontal sinus or mastoid air cells were transgressed during surgery, they were obliterated and/or cranialized. The dura was opened using a "trap door" or stellate technique 32 to facilitate hematoma evacuation and allow for brain swelling, while avoiding transcalvarial herniation across cut dural edges.
Prior to closure, DuraGen was placed underneath or over the native dural leaflets to provide complete coverage of exposed brain surfaces. If a ventricular drain was present, a small opening was made in the DuraGen to allow passage of the drain while still providing complete coverage of the exposed craniectomy defect. As an antiscar device, Gelfilm was then placed over the craniectomy defect and onto the surrounding 1-2 cm of the outer table of the skull beyond the craniectomy defect (Fig. 1) . Care was taken to be sure that the Gelfilm abutted the undersurface of the temporalis muscle to prevent scarring and subsequent adhesion of the muscle and its fascia to underlying dural leaflets and exposed cortical surfaces. If necessary, corners of the Gelfilm were sutured to the native dura to prevent movement of the implant during reflection of the musculocutaneous flap for closure. The autologous bone flaps were packaged in a sterile manner and stored at -70°C in a specialized freezer on site for future reimplantation.
Cranioplasty Technique
Cranioplasty was performed when brain swelling had resolved on physical examination and CT. The scar was reincised and sharp dissection was performed to expose the native bone surfaces, and continued toward the epidural space to fully expose the cut bone edges of the craniectomy defect. The Gelfilm barrier was encountered at the bone edge and was used to identify the epidural space circumferentially. The musculocutaneous flap was separated from the Gelfilm layer and reflected anteriorly, as was also done for the initial decompressive craniectomy surgery. The entire temporalis muscle was elevated with the musculocutaneous flap from the Gelfilm layer, thus separating it from the underlying cortical surface (Fig. 1) . The Gelfilm was then removed, taking care to not leave any fragments behind. Bone edges were defined circumferentially to facilitate replacement of the bone flap into its native position. The defect was closely inspected for signs of CSF leakage; if present, a new sheet of DuraGen was placed over these areas as an onlay repair. The bone flap was then replaced and secured in position using titanium plates and screws. The temporalis muscle fascia, galea, and skin were then closed in layers.
Clinical Outcomes Data
Surgeon and anesthesia operative records were reviewed to document intraoperative findings, estimated blood loss, and operative time. Computed tomography scans of the head obtained before and after cranioplasty were evaluated for the presence of temporalis muscle injury, cortical hemorrhage/IPH, or extraaxial fluid collections. Postcranioplasty fluid collections were consid-ered significant if the greatest thickness was at least 10 mm and/or there was resultant midline shift of at least 5 mm. Follow-up CT scans were reviewed for evidence of hydrocephalus or delayed extraaxial fluid collections. Hydrocephalus was diagnosed if serial CT scans demonstrated progressive ventricular enlargement that was not attributable to loss of brain parenchyma and/or resolution of cortical swelling. Infection was classified as before or after cranioplasty, and defined as scalp erythema, purulent drainage, or skin breakdown at the craniectomy site. All infections were identified with a contrast-enhanced head CT scan or brain MR image.
Results
Patient Series
Between December 2007 and January 2011, 62 patients underwent decompressive craniectomy and subsequent cranioplasty using the modified multilayer technique with absorbable gelatin film. Adult patients (≥ 18 years old) accounted for 77.4% of patients, including 37 men and 25 women. Indications for decompressive craniectomy included midline shift in 37 patients and elevated ICP refractory to maximal medical therapy in 25 patients. Neurological insults included TBI (n = 44), ischemic stroke (n = 9), spontaneous IPH (n = 7), and SAH (n = 2). Fifty-three patients underwent unilateral hemicraniectomy (90.3%), with 36 right-sided and 20 left-sided operations (Table 1 ). All patients underwent replacement of their native bone flap at the time of cranioplasty.
Cranioplasty Procedure
Cranioplasty was performed a median of 54 days (range 19-262 days) after the initial decompressive craniectomy procedure. In all cases, the surgeon's operative note described an intact gelatin film barrier, resulting in a preserved plane between the dura/brain and the overlying tissues of the musculocutaneous flap (galea aponeurotica and temporalis muscle). Sharp dissection of the temporalis muscle from the underlying brain surface was necessary in 2 of 62 cases, both of which described the absence of Gelfilm in the caudal temporal space, deep to the temporalis muscle. The median operative time for cranioplasty was 120.06 minutes (mean 147 ± 42 minutes). The mean estimated blood loss was 213 ± 24 ml (Table 2 ). There were no documented intraoperative complications in this series. A representative CT scan after decompressive craniectomy (left panels) and cranioplasty (right panels) is presented in Fig. 2 .
Clinical Outcomes
Postoperative CT scans obtained within 48 hours of cranioplasty did not reveal any cases of cortical injury or temporalis muscle hemorrhage. Eight patients developed extraaxial collections after cranioplasty, all of which were managed conservatively and demonstrated eventual resolution on follow-up CT. One patient required reoperation for evacuation of a subdural hematoma. Eleven patients developed hydrocephalus, 9 of whom underwent VP shunt placement and the remaining 2 resolved with close observation (Table 2) . Infections after decompressive craniectomy occurred in 4 patients (6.5%), and infections after cranioplasty occurred in 4 separate patients (6.5%). All infections after decompressive craniectomy were treated with irrigation and debridement of the wound, and treatment with at least 6 weeks of intravenous antibiotics. Cranioplasty was performed 2-8 months after irrigation and debridement, with replacement of native bone flaps. None of these early-infected patients developed subsequent infections after cranioplasty. Of the 4 patients who developed infection after cranioplasty, 3 were patients with TBI and 1 had malignant MCA infarction. All 4 underwent cranioplasty more than 60 days after decompressive surgery.
Two patients with infections after cranioplasty were treated with removal of the bone flap, irrigation and debridement of the wound, and treatment with at least 6 weeks of intravenous antibiotics. Subsequent cranioplasty was performed 4-5 months after removal of the bone flap using a custom-made implant (n = 2) with satisfactory outcome. One patient with infection after cranioplasty was treated with 6 weeks of intravenous antibiotics without removal of the bone flap, with no complications. One patient with infection after cranioplasty died prior to repeat cranioplasty due to an unrelated medical condition.
Discussion
This study demonstrates that a multilayered repair technique can be safely used in adult and pediatric patients undergoing unilateral or bilateral decompressive craniectomy for treatment of elevated ICP and midline shift. The decompressive craniectomy technique described in this paper did not significantly affect operative time or blood loss when compared with data from other series, which report 60.4-172.5 minutes and 58-452 ml, respectively. 6, 20, 38 The wound infection rate was 6.5%, which is also within the expected range of 1%-14.3%. 1, 5, 10, 16, 27, 30, 36, 41 Cranioplasty with replacement of the native bone flap was performed a median of 54 days after decompressive craniectomy, and in all cases the gelatin film barrier was still intact and there were no significant adhesions between the components of the musculocutaneous flap and the underlying brain/dura. Sharp dissection was only necessary in 2 cases (3.2%) where the Gelfilm implant did not completely cover the cranial defect under the temporalis muscle. The incidence of wound infections (6.5%) and shunt-dependent hydrocephalus (14.5%) following cranioplasty in this series was consistent with other recent reports. 1, 14, 16 A multilayered repair technique for decompressive craniectomy results in technically simpler and fast cranioplasty surgery, which may result in improved clinical outcomes.
Multilayered Repair
The formation of scar tissue or adhesions between the musculocutaneous flap and intracranial contents (brain and dura) is a consequence of craniectomy and makes subsequent cranioplasty more tedious and may increase operative morbidity. 3, 20, 24, 25, 36, 38 As a result, various authors have described the importance of creating a barrier between the flap and underlying brain, but all have focused on a single-layer technique to repair the dural defect. 3, 20, 25, 38 Dural repair options include temporalis muscle fascia, 10,17 the waterproof fabric Gore-Tex, 25, 38, 40 and various silicone-based materials. 3, 20 Many neurosurgeons use DuraGen or Durepair, allogeneic collagen matrices that can be sutured into position or used as an onlay in the subdural or epidural space. DuraGen typically becomes incorporated into the dura by allowing ingrowth of connective tissue with dura-like properties, 15 and is often used to treat and prevent CSF leaks in both cranial 8, 22, 33 and spinal 28 procedures. An important limitation of DuraGen as single-layer repair in decompressive craniectomy surgery, however, is that it does not prevent adhesion formation between the musculocutaneous flap and the underlying dural repair.
To effectively prevent epidural adhesion formation following decompressive craniectomy surgery, Gelfilm can be used as an antiscar device. Gelfilm is a nonadhesive gelatin film with a thickness of approximately 0.075 mm. In its dry packaged form, Gelfilm has the appearance and texture of cellophane of equivalent thickness; when hydrated, it has the consistency of rubber and maintains its structural integrity for 2-5 months when implanted for neurosurgical applications. Gelfilm slowly resorbs over time and has been successfully used in cardiac surgery, otolaryngology, and other staged operations to prevent the development of adhesions. 21, 23, 29 Gelfilm is labeled for use in neurosurgery as a dural substitute and to prevent meningocerebral adhesions. Therefore, our use of Gelfilm as an antiscar device in the epidural space is technically off-label. Nevertheless, as demonstrated in the surgical series presented here, we believe it is indicated for use in the epidural space as an antiscar device following decompressive craniectomy.
Risks Associated With Decompressive Craniectomy and Cranioplasty
The multilayered decompressive craniectomy technique used in this series simplified the technical complexity associated with safely elevating the musculocutaneous flap during cranioplasty surgery. This is a significant advantage of the multilayered technique, because extensive adhesions between the musculocutaneous scalp flap and the underlying brain and dura significantly increase operative risks and extend operative time. 3, 20, 24, 25, 36, 38 The implantation of additional foreign material (Gelfilm) did not correlate with an increased infection rate in this clinical series. Wound infections occurred in 4 patients (6.5%) after cranioplasty, a rate that is comparable to previous reports that range from 1% to 14.3%. 1, 5, 10, 16, 27, 30, 36, 41 These data suggest that the multilayered technique does not expose patients to an increased risk of infection.
Another complication of decompressive craniectomy is the development of hydrocephalus, which occurs in 2%-29% of patients. 1, 5, 10, 16, 30, 36, 41 Hydrocephalus was present in 11 patients in our series, 9 of whom (14.5% of the population) required placement of a VP shunt. This rate is consistent with a recent publication by Honeybul and Ho, 14 who reported a 14% incidence of VP shunt placement after craniectomy/cranioplasty.
Extraaxial fluid collections after cranioplasty occurred in 9 patients: 1 (1.6%) required reoperation for evacuation of a subdural hematoma, and the rest were successfully managed conservatively. Our experience is similar to a report by Gooch and colleagues, 9 who found that 2 (3.2%) of 62 patients developed extraaxial fluid collections after cranioplasty that required reoperation. In a recent report by Stephens et al., 35 7.4% of patients developed extraaxial hematomas after cranioplasty.
In our 2 cases requiring sharp dissection in the epidural plane, both involved adhesions in the region of the temporalis muscle. It is the experience of the authors that in traditional cranial repair surgeries following craniectomy, the densest adhesions are encountered in the region deep to the temporalis muscle. Defects in the dural repair may result in direct musculoleptomeningeal cicatrization, which poses a risk of cortical injury during muscle elevation. One option is to leave part of the temporalis attached to the brain and deep to the replaced bone flap, although the potential exists for seizures and/or headache from brain and dural irritation, respectively. Additionally, and theoretically, an encephaloduromyosynangiosis could form in the time interval between craniectomy and cranioplasty, in which the pia recruits and becomes dependent on a temporalis muscular blood supply. In this situation, cranioplasty with muscle elevation could compromise this supply. Placing Gelfilm deep to the temporalis muscle in the epidural space at the time of craniectomy ensures that both of these potential situations are avoided.
Conclusions
A modified multilayered technique, using a collagenbased dural substitute onlay and a gelatin film barrier to prevent scar formation, has the following potential advantages: 1) addresses both the dural defect as well as the absence of bone; 2) prevents adhesions between the musculocutaneous flap and intracranial contents; and 3) makes the cranioplasty surgery technically simpler and safer to perform. This technique does not increase the risks normally associated with decompressive craniectomy and subsequent cranioplasty, and may improve patient outcomes. Therefore, the neurosurgical indications for Gelfilm should include its use in the epidural space following decompressive craniectomy.
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